What were Poly Medicure Ltd's latest quarterly results?
Poly Medicure Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -29.3%
- Revenue Growth YoY: +21.3%
- Operating Margin: 21.0%
Poly Medicure Ltd: Stock Analysis & Fundamentals
Updated this weekPoly Medicure Ltd (Medical Equipment) — fundamental analysis, earnings data, and key metrics. PE: 51.1. ROE: 11.2%. This stock is not currently in the Nifty 500 momentum outperformers list.
Poly Medicure Ltd Key Facts
What's Happening
💪Debt reduced 32% YoY — balance sheet strengthening
🌐FII stake decreased 2.1% this quarter
🏛️DII accumulation — stake up 1.2%
Key Numbers
Current Price
₹1,651
Dividend Yield
0.21%
Market Cap
16.7K Cr
Valuation
N/AOther Top Medical Equipment Stocks Beating Nifty 500
Frequently Asked Questions: Poly Medicure Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Poly Medicure Ltd's current PE ratio?
Poly Medicure Ltd's current PE ratio is 51.1x.
- Current PE: 51.1x
- Market Cap: 16.7K Cr
- Dividend Yield: 0.21%
What is Poly Medicure Ltd's price-to-book ratio?
Poly Medicure Ltd's price-to-book ratio is 5.4x.
- Price-to-Book (P/B): 5.4x
- Book Value per Share: ₹306
- Current Price: ₹1651
Is Poly Medicure Ltd a fundamentally strong company?
Poly Medicure Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 14.0%
Is Poly Medicure Ltd debt free?
Poly Medicure Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹354 Cr
What is Poly Medicure Ltd's return on equity (ROE) and ROCE?
Poly Medicure Ltd's return ratios over recent years
- FY2024: ROCE 24.0%
- FY2025: ROCE 20.0%
- FY2026: ROCE 14.0%
Is Poly Medicure Ltd's cash flow positive?
Poly Medicure Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹246 Cr
- Free Cash Flow (FCF): ₹21 Cr
- CFO/PAT Ratio: 77% (adequate)
What is Poly Medicure Ltd's dividend yield?
Poly Medicure Ltd's current dividend yield is 0.21%.
- Dividend Yield: 0.21%
- Current Price: ₹1651
Who holds Poly Medicure Ltd shares — promoters, FII, DII?
Poly Medicure Ltd's shareholding pattern (Mar 2026)
- Promoters: 62.4%
- FII (Foreign): 5.9%
- DII (Domestic): 15.6%
- Public: 16.1%
Is promoter holding increasing or decreasing in Poly Medicure Ltd?
Poly Medicure Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 62.4% (Mar 2026)
- Previous Quarter: 62.4% (Dec 2025)
- Change: 0.00% (stable)
Is Poly Medicure Ltd a new momentum entry or an established outperformer?
Poly Medicure Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Poly Medicure Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Poly Medicure Ltd may be worth studying
- Cash flow is positive — CFO ₹246 Cr
What is the investment thesis for Poly Medicure Ltd?
Poly Medicure Ltd investment thesis summary:
What is the future outlook for Poly Medicure Ltd?
Poly Medicure Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.